| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 90245017012 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90248017012 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90252017012 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90265017012 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90266017012 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90217017012 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90229017012 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90232017012 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90237017012 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90239017012 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 80012817002_1 | Group:QC-ExternalStandard | Timepoint:0 hour | Sex:- | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 80012817002_2 | Group:QC-ExternalStandard | Timepoint:0 hour | Sex:- | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 80012817002_3 | Group:QC-ExternalStandard | Timepoint:0 hour | Sex:- | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 80012817002_4 | Group:QC-ExternalStandard | Timepoint:0 hour | Sex:- | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 80013827002_1 | Group:QC-ExternalStandard | Timepoint:0 hour | Sex:- | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 80013827002_2 | Group:QC-ExternalStandard | Timepoint:0 hour | Sex:- | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 80013827002_3 | Group:QC-ExternalStandard | Timepoint:0 hour | Sex:- | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 80013827002_4 | Group:QC-ExternalStandard | Timepoint:0 hour | Sex:- | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90559017012 | Group:Training | Timepoint:1 week of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90560017012 | Group:Training | Timepoint:1 week of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90564017012 | Group:Training | Timepoint:1 week of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90567017012 | Group:Training | Timepoint:1 week of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90571017012 | Group:Training | Timepoint:1 week of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90421017012 | Group:Training | Timepoint:1 week of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90422017012 | Group:Training | Timepoint:1 week of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90423017012 | Group:Training | Timepoint:1 week of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90426017012 | Group:Training | Timepoint:1 week of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90430017012 | Group:Training | Timepoint:1 week of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90576017012 | Group:Training | Timepoint:2 weeks of training | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90578017012 | Group:Training | Timepoint:2 weeks of training | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90581017012 | Group:Training | Timepoint:2 weeks of training | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90585017012 | Group:Training | Timepoint:2 weeks of training | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90587017012 | Group:Training | Timepoint:2 weeks of training | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90439017012 | Group:Training | Timepoint:2 weeks of training | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90441017012 | Group:Training | Timepoint:2 weeks of training | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90444017012 | Group:Training | Timepoint:2 weeks of training | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90449017012 | Group:Training | Timepoint:2 weeks of training | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90450017012 | Group:Training | Timepoint:2 weeks of training | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90406017012 | Group:Training | Timepoint:4 weeks of training | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90410017012 | Group:Training | Timepoint:4 weeks of training | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90412017012 | Group:Training | Timepoint:4 weeks of training | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90416017012 | Group:Training | Timepoint:4 weeks of training | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90420017012 | Group:Training | Timepoint:4 weeks of training | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90280017012 | Group:Training | Timepoint:4 weeks of training | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90281017012 | Group:Training | Timepoint:4 weeks of training | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90283017012 | Group:Training | Timepoint:4 weeks of training | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90289017012 | Group:Training | Timepoint:4 weeks of training | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90292017012 | Group:Training | Timepoint:4 weeks of training | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90251017012 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90254017012 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90258017012 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90259017012 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90267017012 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Female | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90218017012 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90222017012 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90223017012 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90225017012 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Male | pmol/mg of tissue |
| Reversed phase NEGATIVE ION MODE | 90227017012 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Male | pmol/mg of tissue |
Return to study ST002625 main page
Download data matrix(MoTrPAC: Endurance exercise training study in young adult rats, Tissue:White Adipose - Targeted Nucleotides Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|